CME: Schizophrenia: Updates from the American Psychiatric Association Annual Meeting (APA) 2017
ACCREDITATION EXPIRED: July 27, 2019
Activity Description / Statement of Need:
In this online CME self-learning program:
Schizophrenia, by nature, presents manifold challenges to the healthcare professional directing neuropsychiatric care. Not only do practical matters like medication adherence play a role in the success of therapy, but it behooves clinicians to also have a well-informed understanding of the symptomatology and treatment course of the disease. Atypical antipsychotics are the mainstay of initial pharmacotherapy, with oral agents being preferred first. However, recent literature has questioned whether earlier treatment with long-acting injectable antipsychotics might improve adherence or whether other treatment modalities like behavioral intervention strategies should be stressed. Poor patient adherence to schizophrenia medications is associated with suboptimal clinical outcomes, and improving adherence may enhance quality of life and reduce the risk of hospitalization, thereby potentially lowering health resource utilization and its associated costs. Adherence is an area that continues to represent a practice gap.
Agenda
|
- Faculty member introduction, disclosures |
|
- Major findings from APA 2017, including clinical trial data relevant to both community and health-system practice and recognized barriers to implementing those findings in practice (specific content contingent upon conference content) |
|
-Concluding remarks |
-
Target Audience:
Healthcare professionals specializing in: family medicine, internal medicine, mental health, pediatric neurology and psychiatry, or those who otherwise commonly care for pediatric patients with Schizophrenia or related psychiatric diseases.
This program is supported by an educational grant from Alkermes.
Release Date: July 27, 2017 -- Expiration Date: July 27, 2019
Faculty: Rimal Bera, MD
Agenda
Learning Objectives
By the end of the session the participant will be able to:
- Recall the most impactful findings about Schizophrenia from the APA 2017 Annual meeting relating to Schizophrenia pathophysiology, progression, & prognosis.
- Describe the most impactful findings about Schizophrenia from the APA 2017 Annual meeting relating to using the similarities & differences between Schizophrenia & other disorders to inform good clinical care.
- Summarize the most impactful findings about Schizophrenia from the APA 2017 Annual meeting relating to old, new, emerging, and potential new targets for treating of Schizophrenia and apply them to patient cases.
Accreditation
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
Faculty Disclosure and Resolution of COI
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Rimal Bera, M.D. is on the speaker's bureau of Alkermes, Merck, and Otsuka and has received research funding from AZ, Novartis, and Otsuka.
Disclosures of Educational Planners: Charles Turck, PharmD has no relevant conflicts of interest to disclose.
Commercial Support Disclosure: This program is supported by an educational grant from Alkermes
Instructions
- Read the learning objectives above
- Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
- View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
- Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
- Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.
System Requirements
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.
Additional Courses That Are Related To This Activity
Best Practices and Advances in Treatment Strategies in Bipolar Disorder Pharmacotherapy
Alcohol Use Disorder (AUD): Therapeutic Updates and Best Practices
Prevention and Treatment of Stress-Related Disorders Through the Transcendental Meditation Technique